title: [Congestive heart failure, part 2: treatment].
authors.affiliation: Skånes universitetssjukhus, Lund. gustav.smith@med.lu.se
authors.forename: J Gustav
authors.initials: JG
authors.lastname: Smith
authors.forename: Sasha
authors.initials: S
authors.lastname: Kohl
authors.forename: Björn
authors.initials: B
authors.lastname: Kornhall
authors.forename: Björn
authors.initials: B
authors.lastname: Ekmehag
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000493:pharmacokinetics / Q000627:therapeutic use; D000328:Adult; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000493:pharmacokinetics / Q000627:therapeutic use; D002304:Cardiac Pacing, Artificial; D002908:Chronic Disease / Q000188:drug therapy* / Q000628:therapy; D032921:Consensus; D019091:Critical Pathways; D017147:Defibrillators, Implantable; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000628:therapy; D006801:Humans; D000451:Mineralocorticoid Receptor Antagonists / Q000493:pharmacokinetics / Q000627:therapeutic use; D010353:Patient Education as Topic; D018487:Ventricular Dysfunction, Left / Q000188:drug therapy* / Q000628:therapy
chemical_list: D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000451:Mineralocorticoid Receptor Antagonists